SynthesisMolecular medicine (Cambridge, Mass.)2021

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.

Zhendong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.